Lunit Partners with Philips on Chest X-ray AI Solution
Lunit’s INSIGHT CXR software will be available on Philips’ X-ray solutions.
Medical artificial intelligence (AI) start-up Lunit announced, during the 2021 European Congress of Radiology (ECR) annual meeting, that its AI software will now be available on Philips Healthcare’s diagnostic X-ray solutions.
For additional ECR 2021 coverage, click here.
This move marks the latest extension of Philips’ AI portfolio in precision diagnosis. It is designed to improve patient outcomes and experience, according to a company statement.
Lunit INSIGHT CXR detects findings and provides abnormality score on a chest X-ray image
Credit: Lunit
Lunit INSIGHT CXR chest detection suite can identify 10 of the most common findings on chest X-rays by mapping finding locations and displaying a scored calculation of where those findings actually are. By using abnormality scores, the software prioritizes scans, allowing for faster triage of the most critical images.
Based on existing publications, including studies in Radiology and JAMA Network Open, the algorithm can perform with 97 percent to 99 percent accuracy.
This collaboration will potentially accelerate the diagnostic capabilities of facilities, said Daan van Manen, general manager for diagnostic X-ray at Philips.
“Radiology departments and their technologists are continually under pressure. They face high patient volumes, and every improvement in workflow can make a big impact,” Manen said. “Our partnership with Lunit to incorporate their diagnostic AI into our X-ray platform combines with a host of smart workflow features in the Philips Eleva user interface, our common platform across our digital radiography systems that enables a smooth and efficient, patient-focused workflow.”
Lunit INSIGHT CXR is already CE marked and clinically available in Europe, Middle East, Latin America, South East Asia, Australia, and New Zealand. The company expects U.S. Food & Drug Administration clearance this year.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-newsletter here.
Study: AI-Generated ADC Maps from MRI More Than Double Specificity in Prostate Cancer Detection
June 5th 2025Emerging research showed that AI-generated ADC mapping from MRI led to significant increases in accuracy, PPV and specificity in comparison to conventional ADC mapping while achieving a 93 percent sensitivity for PCa.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
